デフォルト表紙
市場調査レポート
商品コード
1475842

血行動態モニタリングシステムの世界市場規模調査&予測、システム別、用途別、地域別分析、2023年~2030年

Global Hemodynamic Monitoring System Market Size Study & Forecast, By System By Application and Regional Analysis, 2023-2030


出版日
ページ情報
英文 200 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
血行動態モニタリングシステムの世界市場規模調査&予測、システム別、用途別、地域別分析、2023年~2030年
出版日: 2024年04月30日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文 200 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

血行動態モニタリングシステムの世界市場は、2022年に約12億米ドルと評価され、予測期間2023-2030年には3.58%以上の健全な成長率で成長すると予測されています。

血流動態モニタリングシステムは、心血管系内の血流と圧力の動態を測定・評価するために設計された医療機器です。これらのシステムは、血圧、心拍出量、体液状態などの主要な血行動態パラメータに関するリアルタイムのデータを臨床医に提供し、心血管機能の評価や治療介入の指針を可能にします。血行動態モニタリングは、集中治療室、手術室、心臓カテーテル検査室など、さまざまな臨床現場で極めて重要であり、血行動態の安定性を最適化し、体液バランスを管理し、心血管疾患や重症の患者をモニタリングするのに役立ちます。ヘモダイナミック・モニタリング・システムは通常、侵襲性または非侵襲性のモニタリング・デバイス、センサー、データ処理ソフトウェアで構成され、心血管パラメータの継続的なモニタリングと分析を可能にすることで、臨床的な意思決定をサポートし、患者の転帰を改善します。ヘモダイナミック・モニタリング・システム市場は、心血管疾患や糖尿病疾患の有病率の上昇、外科手術件数の増加、電子カルテ(EHR)や遠隔医療との統合の高まりなどの要因により拡大しています。

心血管疾患が世界的に増加し続けているため、患者の心血管状態を正確に評価・管理する血行動態モニタリングシステムの必要性が高まっています。2021年の世界保健機関(WHO)のデータによると、世界で30~79歳の成人約12億8,000万人が高血圧に罹患しています。さらに、心血管疾患(CVDs)は世界の死亡の主な原因であり、年間推定1,790万人の命を奪い、世界全体の死亡の約32%を占めています。これらの憂慮すべき統計は、心臓疾患と高血圧が公衆衛生に及ぼす重大な影響を強調しています。その結果、これらの疾患の蔓延が市場の成長を促進すると予想されます。加えて、ヘルスケア支出の増加や医療機器の規制認可の高まりが、市場成長の新たな機会を生み出しています。しかし、侵襲的モニタリングシステムに関連する合併症の発生件数の増加が、2023-2030年の予測期間を通じて市場成長を阻害しています。

血行動態モニタリングシステムの世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。北米は、主にいくつかの要因によって2022年の市場を独占しました。大手市場プレイヤーの存在、病院における最先端技術の広範な採用、同地域のヘルスケア施設内で治療を求める重症患者の流入の増加が、同地域の需要を牽引すると予測されています。さらに、米国食品医薬品局(FDA)によるモニタリング機器の承認や新製品のイントロダクションが、予測期間を通じて米国血行動態モニタリング市場の成長を促進すると予測されています。例えば、2021年9月、Caretaker Medical社は血圧・血行動態患者モニタリングシステムVitalStreamのFDA認可を取得しました。同様に、2021年3月には、ミシガン州を拠点とするリアルタイム臨床分析企業のフィフスアイが、同社の血行動態不安定解析(AHI)ツールが食品医薬品局からDE Novo分類を付与されたことを明らかにしました。アジア太平洋地域は、予測期間中に最も速い速度で成長すると予想されています。これは、重症患者に対する高度な患者モニタリングシステムに対するニーズの高まりに対応するためにヘルスケア支出に重点が置かれていることなどが、市場拡大を後押ししているためです。さらに、高齢化社会と患者モニタリングシステムの進歩を奨励する政府の取り組みが、血行動態管理システムの採用を拡大しており、この地域の市場成長を促進しています。

この調査の目的は、近年のさまざまなセグメントと国の市場規模を明らかにし、今後数年間の値を予測することです。本レポートは、調査対象国における産業の質的・量的側面を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題など、重要な側面に関する詳細情報も掲載しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

第2章 血行動態モニタリングシステムの世界市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 産業の進化
    • 調査範囲
  • 調査対象年
  • 通貨換算レート

第3章 血行動態モニタリングシステムの世界市場力学

  • 血行動態モニタリングシステム市場の影響分析(2020年~2030年)
    • 市場促進要因
      • 心血管疾患と糖尿病疾患の有病率の上昇
      • 手術件数の増加
      • 電子カルテ(EHR)および遠隔医療との統合の増加
    • 市場の課題
      • 侵襲的モニタリングシステムに伴う合併症の増加
      • 非侵襲的モニタリングへの嗜好
    • 市場機会
      • ヘルスケア支出の増加
      • 医療機器の規制承認の増加

第4章 血行動態モニタリングシステムの世界市場産業分析

  • ポーターのファイブフォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターのファイブフォース影響分析
  • PEST分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • COVID-19影響分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 血行動態モニタリングシステムの世界市場:システム別

  • 市場スナップショット
  • 血行動態モニタリングシステムの世界市場:システム別、実績 - ポテンシャル分析
  • 血行動態モニタリングシステムの世界市場:システム別推定・予測、2020年~2030年
  • 血行動態モニタリングシステム市場、サブセグメント分析
    • 低侵襲モニタリングシステム
    • 侵襲的モニタリングシステム
    • 非侵襲性モニタリングシステム

第6章 血行動態モニタリングシステムの世界市場:用途別

  • 市場スナップショット
  • 血行動態モニタリングシステムの世界市場:用途別、実績 - ポテンシャル分析
  • 血行動態モニタリングシステムの世界市場:用途別推定・予測、2020年~2030年
  • 血行動態モニタリングシステム市場、サブセグメント分析
    • ラボベースのモニタリングシステム
    • 在宅モニタリングシステム
    • 病院ベースのモニタリングシステム

第7章 血行動態モニタリングシステムの世界市場:地域別分析

  • 主要国
  • 主な新興国
  • 血行動態モニタリングシステム市場:地域別市場スナップショット
  • 北米
    • 米国
      • システムの推定・予測、2020年~2030年
      • 用途の推定・予測、2020年~2030年
    • カナダ
  • 欧州の血行動態モニタリングシステム市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他の欧州
  • アジア太平洋の血行動態モニタリングシステム市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他のアジア太平洋
  • ラテンアメリカの血行動態モニタリングシステム市場スナップショット
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • その他の中東・アフリカ

第8章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • LiDCO Group PLC
      • 主要情報
      • 概要
      • 財務(データの入手可能性によります)
      • 製品概要
      • 最近の動向
    • Baxter(Cheetah Medical Inc.)
    • ICU Medical Inc.
    • Tensys Medical Inc.
    • Schwarzer Cardiotek GmbH
    • Koninklijke Philips NV
    • Edwards Lifesciences Corporation
    • Getinge Group
    • GE Healthcare
    • Draeger Medical

第9章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
  • 調査前提条件
図表

LIST OF TABLES

  • TABLE 1.Global Hemodynamic Monitoring System Market, report scope
  • TABLE 2.Global Hemodynamic Monitoring System Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3.Global Hemodynamic Monitoring System Market estimates & forecasts by System 2020-2030 (USD Billion)
  • TABLE 4.Global Hemodynamic Monitoring System Market estimates & forecasts by Application 2020-2030 (USD Billion)
  • TABLE 5.Global Hemodynamic Monitoring System Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 6.Global Hemodynamic Monitoring System Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 7.Global Hemodynamic Monitoring System Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8.Global Hemodynamic Monitoring System Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9.Global Hemodynamic Monitoring System Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10.Global Hemodynamic Monitoring System Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11.Global Hemodynamic Monitoring System Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12.Global Hemodynamic Monitoring System Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13.Global Hemodynamic Monitoring System Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14.Global Hemodynamic Monitoring System Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15.U.S. Hemodynamic Monitoring System Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16.U.S. Hemodynamic Monitoring System Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 17.U.S. Hemodynamic Monitoring System Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 18.Canada Hemodynamic Monitoring System Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 19.Canada Hemodynamic Monitoring System Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 20.Canada Hemodynamic Monitoring System Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21.UK Hemodynamic Monitoring System Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 22.UK Hemodynamic Monitoring System Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 23.UK Hemodynamic Monitoring System Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24.Germany Hemodynamic Monitoring System Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 25.Germany Hemodynamic Monitoring System Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 26.Germany Hemodynamic Monitoring System Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27.France Hemodynamic Monitoring System Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 28.France Hemodynamic Monitoring System Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 29.France Hemodynamic Monitoring System Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30.Italy Hemodynamic Monitoring System Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 31.Italy Hemodynamic Monitoring System Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 32.Italy Hemodynamic Monitoring System Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33.Spain Hemodynamic Monitoring System Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 34.Spain Hemodynamic Monitoring System Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 35.Spain Hemodynamic Monitoring System Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36.RoE Hemodynamic Monitoring System Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 37.RoE Hemodynamic Monitoring System Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 38.RoE Hemodynamic Monitoring System Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39.China Hemodynamic Monitoring System Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 40.China Hemodynamic Monitoring System Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 41.China Hemodynamic Monitoring System Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42.India Hemodynamic Monitoring System Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 43.India Hemodynamic Monitoring System Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 44.India Hemodynamic Monitoring System Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45.Japan Hemodynamic Monitoring System Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 46.Japan Hemodynamic Monitoring System Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 47.Japan Hemodynamic Monitoring System Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48.South Korea Hemodynamic Monitoring System Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 49.South Korea Hemodynamic Monitoring System Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 50.South Korea Hemodynamic Monitoring System Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51.Australia Hemodynamic Monitoring System Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 52.Australia Hemodynamic Monitoring System Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 53.Australia Hemodynamic Monitoring System Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54.RoAPAC Hemodynamic Monitoring System Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 55.RoAPAC Hemodynamic Monitoring System Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 56.RoAPAC Hemodynamic Monitoring System Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57.Brazil Hemodynamic Monitoring System Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 58.Brazil Hemodynamic Monitoring System Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 59.Brazil Hemodynamic Monitoring System Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60.Mexico Hemodynamic Monitoring System Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 61.Mexico Hemodynamic Monitoring System Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 62.Mexico Hemodynamic Monitoring System Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63.RoLA Hemodynamic Monitoring System Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 64.RoLA Hemodynamic Monitoring System Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 65.RoLA Hemodynamic Monitoring System Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66.Saudi Arabia Hemodynamic Monitoring System Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 67.South Africa Hemodynamic Monitoring System Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 68.RoMEA Hemodynamic Monitoring System Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69.List of secondary sources, used in the study of global Hemodynamic Monitoring System Market
  • TABLE 70.List of primary sources, used in the study of global Hemodynamic Monitoring System Market
  • TABLE 71.Years considered for the study
  • TABLE 72.Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1.Global Hemodynamic Monitoring System Market, research methodology
  • FIG 2.Global Hemodynamic Monitoring System Market, Market estimation techniques
  • FIG 3.Global Market size estimates & forecast methods
  • FIG 4.Global Hemodynamic Monitoring System Market, key trends 2022
  • FIG 5.Global Hemodynamic Monitoring System Market, growth prospects 2023-2030
  • FIG 6.Global Hemodynamic Monitoring System Market, porters 5 force model
  • FIG 7.Global Hemodynamic Monitoring System Market, pest analysis
  • FIG 8.Global Hemodynamic Monitoring System Market, value chain analysis
  • FIG 9.Global Hemodynamic Monitoring System Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10.Global Hemodynamic Monitoring System Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11.Global Hemodynamic Monitoring System Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12.Global Hemodynamic Monitoring System Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13.Global Hemodynamic Monitoring System Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14.Global Hemodynamic Monitoring System Market, regional snapshot 2020 & 2030
  • FIG 15.North America Hemodynamic Monitoring System Market 2020 & 2030 (USD Billion)
  • FIG 16.Europe Hemodynamic Monitoring System Market 2020 & 2030 (USD Billion)
  • FIG 17.Asia Pacific Hemodynamic Monitoring System Market 2020 & 2030 (USD Billion)
  • FIG 18.Latin America Hemodynamic Monitoring System Market 2020 & 2030 (USD Billion)
  • FIG 19.Middle East & Africa Hemodynamic Monitoring System Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Hemodynamic Monitoring System Market is valued at approximately USD 1.20 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 3.58% over the forecast period 2023-2030. Hemodynamic monitoring systems are medical devices designed to measure and assess the dynamics of blood flow and pressure within the cardiovascular system. These systems provide clinicians with real-time data on key hemodynamic parameters such as blood pressure, cardiac output, and fluid status, enabling them to evaluate cardiovascular function and guide therapeutic interventions. Hemodynamic monitoring is crucial in various clinical settings, including intensive care units, operating rooms, and cardiac catheterization labs, where it helps to optimize hemodynamic stability, manage fluid balance, and monitor patients with cardiovascular diseases or critical illnesses. Hemodynamic monitoring systems typically consist of invasive or non-invasive monitoring devices, sensors, and data processing software, allowing for continuous monitoring and analysis of cardiovascular parameters to support clinical decision-making and improve patient outcomes. The Hemodynamic Monitoring System market is expanding because of factors such as the rising prevalence of cardiovascular and diabetes diseases, the growing number of surgical procedures, and rising integration with Electronic Health Records (EHR) and telemedicine.

As cardiovascular diseases continue to rise globally, there is a growing need for hemodynamic monitoring systems to accurately assess and manage patients' cardiovascular status. According to data from the World Health Organization in 2021, approximately 1.28 billion adults aged 30-79 worldwide are affected by hypertension. Moreover, Cardiovascular diseases (CVDs) stand as the primary cause of mortality globally, claiming an estimated 17.9 million lives annually, constituting approximately 32% of all global deaths. These alarming statistics underscore the significant impact of cardiac disorders and hypertension on public health. Consequently, the prevalence of these conditions is anticipated to drive market growth. In addition, rising healthcare expenditures and rising regulatory approval of medical devices are creating new opportunities for market growth. However, increasing incidences of complications associated with invasive monitoring systems stifle market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Hemodynamic Monitoring System Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 primarily driven by several factors. The substantial presence of major market players, the widespread adoption of cutting-edge technologies in hospitals, and the rising influx of critically ill patients seeking treatment within the region's healthcare facilities are expected to drive regional demand. Furthermore, the United States Food and Drug Administration (FDA) approvals for monitoring devices and the introduction of new products are anticipated to fuel growth in the United States hemodynamic monitoring market throughout the forecast period. For instance, in September 2021, Caretaker Medical received FDA clearance for its blood pressure and hemodynamic patient monitoring system, VitalStream. Similarly, in March 2021, Fifth Eye, a Michigan-based real-time clinical analytics company, revealed that its Analytic for Hemodynamic Instability (AHI) tool had been granted DE Novo classification by the Food and Drug Administration. Asia Pacific is expected to grow at the fastest rate during the forecast period, owing to factors such as heightened emphasis on healthcare expenditure to meet the growing need for sophisticated patient monitoring systems for critically ill individuals is driving market expansion. Additionally, the aging population and governmental efforts to encourage advancements in patient monitoring systems are amplifying the adoption of hemodynamic control systems, thus propelling market growth in the region.

Major market players included in this report are:

  • LiDCO Group PLC
  • Baxter (Cheetah Medical Inc.)
  • ICU Medical Inc.
  • Tensys Medical Inc.
  • Schwarzer Cardiotek GmbH
  • Koninklijke Philips NV
  • Edwards Lifesciences Corporation
  • Getinge Group
  • GE Healthcare
  • Draeger Medical

Recent Developments in the Market:

  • In October 2023, Masimo obtained CE approval for the LiDCO board-in-cable (BIC) module, enhancing its portfolio of hemodynamic monitoring systems and signaling its commitment to expanding product offerings in this field.
  • In April 2022, Caretaker Medical secured FDA approval for a wireless wearable monitor designed for continuous blood pressure monitoring and advanced hemodynamics. This approval strengthens Caretaker Medical's global product portfolio, underscoring its dedication to providing innovative solutions in the healthcare market.

Global Hemodynamic Monitoring System Market Report Scope:

  • Historical Data - 2020 - 2021
  • Base Year for Estimation - 2022
  • Forecast period - 2023-2030
  • Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered - System, Application, Region
  • Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope - Free report customization (equivalent to up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters to detailed information about the crucial aspects such as driving factors & challenges that will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By System:

  • Minimally Invasive Monitoring Systems
  • Invasive Monitoring Systems
  • Non-invasive Monitoring Systems

By Application:

  • Laboratory-based Monitoring Systems
  • Home-based Monitoring Systems
  • Hospital-based Monitoring Systems

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1.Executive Summary

  • 1.1.Market Snapshot
  • 1.2.Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1.Hemodynamic Monitoring System Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2.Hemodynamic Monitoring System Market, by System, 2020-2030 (USD Billion)
    • 1.2.3.Hemodynamic Monitoring System Market, by Application, 2020-2030 (USD Billion)
  • 1.3.Key Trends
  • 1.4.Estimation Methodology
  • 1.5.Research Assumption

Chapter 2.Global Hemodynamic Monitoring System Market Definition and Scope

  • 2.1.Objective of the Study
  • 2.2.Market Definition & Scope
    • 2.2.1.Industry Evolution
    • 2.2.2.Scope of the Study
  • 2.3.Years Considered for the Study
  • 2.4.Currency Conversion Rates

Chapter 3.Global Hemodynamic Monitoring System Market Dynamics

  • 3.1.Hemodynamic Monitoring System Market Impact Analysis (2020-2030)
    • 3.1.1.Market Drivers
      • 3.1.1.1.Rising Prevalence of Cardiovascular and Diabetes Diseases
      • 3.1.1.2.Growing Number of Surgical Procedures
      • 3.1.1.3.Rising Integration with Electronic Health Records (EHR And Telemedicine
    • 3.1.2.Market Challenges
      • 3.1.2.1.Increasing Incidences of Complications Associated with Invasive Monitoring Systems
      • 3.1.2.2.Preference for Non-Invasive Monitoring
    • 3.1.3.Market Opportunities
      • 3.1.3.1.Rising Healthcare Expenditure
      • 3.1.3.2.Rising Regulatory Approval of Medical Devices

Chapter 4.Global Hemodynamic Monitoring System Market Industry Analysis

  • 4.1.Porter's 5 Force Model
    • 4.1.1.Bargaining Power of Suppliers
    • 4.1.2.Bargaining Power of Buyers
    • 4.1.3.Threat of New Entrants
    • 4.1.4.Threat of Substitutes
    • 4.1.5.Competitive Rivalry
  • 4.2.Porter's 5 Force Impact Analysis
  • 4.3.PEST Analysis
    • 4.3.1.Political
    • 4.3.2.Economical
    • 4.3.3.Social
    • 4.3.4.Technological
    • 4.3.5.Environmental
    • 4.3.6.Legal
  • 4.4.Top investment opportunity
  • 4.5.Top winning strategies
  • 4.6.COVID-19 Impact Analysis
  • 4.7.Disruptive Trends
  • 4.8.Industry Expert Perspective
  • 4.9.Analyst Recommendation & Conclusion

Chapter 5.Global Hemodynamic Monitoring System Market, by System

  • 5.1.Market Snapshot
  • 5.2.Global Hemodynamic Monitoring System Market by System, Performance - Potential Analysis
  • 5.3.Global Hemodynamic Monitoring System Market Estimates & Forecasts by System 2020-2030 (USD Billion)
  • 5.4.Hemodynamic Monitoring System Market, Sub Segment Analysis
    • 5.4.1. Minimally Invasive Monitoring Systems
    • 5.4.2.Invasive Monitoring Systems
    • 5.4.3.Non-invasive Monitoring Systems

Chapter 6.Global Hemodynamic Monitoring System Market, by Application

  • 6.1.Market Snapshot
  • 6.2.Global Hemodynamic Monitoring System Market by Application, Performance - Potential Analysis
  • 6.3.Global Hemodynamic Monitoring System Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
  • 6.4.Hemodynamic Monitoring System Market, Sub Segment Analysis
    • 6.4.1. Laboratory-based Monitoring Systems
    • 6.4.2.Home-based Monitoring Systems
    • 6.4.3.Hospital-based Monitoring Systems

Chapter 7.Global Hemodynamic Monitoring System Market, Regional Analysis

  • 7.1.Top Leading Countries
  • 7.2.Top Emerging Countries
  • 7.3.Hemodynamic Monitoring System Market, Regional Market Snapshot
  • 7.4.North America Hemodynamic Monitoring System Market
    • 7.4.1.U.S. Hemodynamic Monitoring System Market
      • 7.4.1.1.System breakdown estimates & forecasts, 2020-2030
      • 7.4.1.2.Application breakdown estimates & forecasts, 2020-2030
    • 7.4.2.Canada Hemodynamic Monitoring System Market
  • 7.5.Europe Hemodynamic Monitoring System Market Snapshot
    • 7.5.1.U.K. Hemodynamic Monitoring System Market
    • 7.5.2.Germany Hemodynamic Monitoring System Market
    • 7.5.3.France Hemodynamic Monitoring System Market
    • 7.5.4.Spain Hemodynamic Monitoring System Market
    • 7.5.5.Italy Hemodynamic Monitoring System Market
    • 7.5.6.Rest of Europe Hemodynamic Monitoring System Market
  • 7.6.Asia-Pacific Hemodynamic Monitoring System Market Snapshot
    • 7.6.1.China Hemodynamic Monitoring System Market
    • 7.6.2.India Hemodynamic Monitoring System Market
    • 7.6.3.Japan Hemodynamic Monitoring System Market
    • 7.6.4.Australia Hemodynamic Monitoring System Market
    • 7.6.5.South Korea Hemodynamic Monitoring System Market
    • 7.6.6.Rest of Asia Pacific Hemodynamic Monitoring System Market
  • 7.7.Latin America Hemodynamic Monitoring System Market Snapshot
    • 7.7.1.Brazil Hemodynamic Monitoring System Market
    • 7.7.2.Mexico Hemodynamic Monitoring System Market
  • 7.8.Middle East & Africa Hemodynamic Monitoring System Market
    • 7.8.1.Saudi Arabia Hemodynamic Monitoring System Market
    • 7.8.2.South Africa Hemodynamic Monitoring System Market
    • 7.8.3.Rest of Middle East & Africa Hemodynamic Monitoring System Market

Chapter 8.Competitive Intelligence

  • 8.1.Key Company SWOT Analysis
  • 8.2.Top Market Strategies
  • 8.3.Company Profiles
    • 8.3.1. LiDCO Group PLC
      • 8.3.1.1.Key Information
      • 8.3.1.2.Overview
      • 8.3.1.3.Financial (Subject to Data Availability)
      • 8.3.1.4.Product Summary
      • 8.3.1.5.Recent Developments
    • 8.3.2. Baxter (Cheetah Medical Inc.)
    • 8.3.3.ICU Medical Inc.
    • 8.3.4.Tensys Medical Inc.
    • 8.3.5.Schwarzer Cardiotek GmbH
    • 8.3.6.Koninklijke Philips NV
    • 8.3.7.Edwards Lifesciences Corporation
    • 8.3.8.Getinge Group
    • 8.3.9.GE Healthcare
    • 8.3.10.Draeger Medical

Chapter 9.Research Process

  • 9.1.Research Process
    • 9.1.1.Data Mining
    • 9.1.2.Analysis
    • 9.1.3.Market Estimation
    • 9.1.4.Validation
    • 9.1.5.Publishing
  • 9.2.Research Attributes
  • 9.3.Research Assumption